Related Experiment Video
Updated: May 31, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Trimethoprim-sulphamethoxazole-associated rhabdomyolysis in an HIV-infected patient
Abstract:
We describe a case of rhabdomyolysis associated with trimethoprim-sulphamethoxazole (TMP-SMZ) in a HIV-infected patient. A 33-year-old African American man with newly diagnosed AIDS initially presented with persistent, high-grade fevers suspected to be TMP-SMZ-related drug fever. The antibiotic was discontinued while in the hospital, but the patient was restarted on TMP-SMZ following discharge. Two days later, he returned to the hospital with severe muscle pain, acute renal failure and a significantly elevated creatine phosphokinase consistent with rhabdomyolysis. The patient gradually improved following discontinuation of TMP-SMZ.
Insights
Trimethoprim-sulfamethoxazole (TMP-SMZ) can cause rhabdomyolysis in HIV patients. Discontinuing TMP-SMZ led to recovery in a case of severe muscle pain and acute kidney injury.
Area of Science:
- Infectious Diseases
- Pharmacology
- Nephrology
Background:
- Human Immunodeficiency Virus (HIV) infection is associated with various opportunistic infections and drug toxicities.
- Trimethoprim-sulfamethoxazole (TMP-SMZ) is a common antibiotic used for prophylaxis and treatment in HIV-infected individuals.
- Drug-induced rhabdomyolysis is a rare but serious adverse effect of certain medications.
Observation:
- A 33-year-old male with newly diagnosed Acquired Immunodeficiency Syndrome (AIDS) presented with high fevers attributed to TMP-SMZ.
- Following hospital discharge, the patient was restarted on TMP-SMZ and subsequently developed severe myalgia, acute renal failure, and elevated creatine phosphokinase.
- These clinical and laboratory findings were consistent with rhabdomyolysis.
Findings:
- The case highlights a potential association between TMP-SMZ and the development of rhabdomyolysis in an HIV-infected patient.
- Discontinuation of TMP-SMZ resulted in gradual clinical improvement and resolution of acute kidney injury.
- This suggests TMP-SMZ may have contributed to the rhabdomyolysis in this specific patient context.
Implications:
- Clinicians should consider TMP-SMZ as a potential cause of rhabdomyolysis in HIV-infected patients presenting with unexplained myopathy and renal dysfunction.
- Awareness of this adverse effect is crucial for prompt diagnosis and management, potentially preventing severe complications.
- Further investigation may be warranted to elucidate the mechanism of TMP-SMZ-induced rhabdomyolysis in immunocompromised individuals.
Related Concept Videos
Cryptococcal Meningitis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Nephrotic Syndrome I : Introduction
Retrovirus Life Cycles
Antiprotozoal Agents
Rocky Mountain Spotted Fever
